# Neuroglee Health

> Neuroglee Health is a Boston-based digital health company building value-based, at-home dementia and cognitive care. It pairs a virtual interdisciplinary clinical team - advanced practice nurses, social workers, pharmacists and care navigators supervised by neurologists and geriatric psychiatrists - with evidence-based digital therapeutics to support patients with mild cognitive impairment through late-stage dementia and their care partners. Founded in 2020 by Aniket Singh Rajput, the company works with Mayo Clinic on its Neuroglee Connect platform and participates in the CMS GUIDE Model to deliver comprehensive, longitudinal dementia care to Medicare beneficiaries at no cost to families.

- **Founded:** 2020
- **Headquarters:** Boston, Massachusetts, United States
- **Founders:** Aniket Singh Rajput (Founder & CEO), Sundeep Krishna Mohan Badiga (Co-Founder)
- **Team size:** ~13 employees
- **Products:** Neuroglee Connect, Medicare GUIDE Program, Virtual Interdisciplinary Care Team, NG-001
- **Notable:** Selected for the CMS Innovation Center's GUIDE Model for value-based dementia care, Raised $12.3M total, including a $10M Series A led by Openspace Ventures and EDBI, Established a multi-year collaboration with Mayo Clinic on the Neuroglee Connect platform

## Products & services

- **Neuroglee Connect** — A virtual dementia and cognitive care platform developed with Mayo Clinic, guided by the principles of Mayo's HABIT (Healthy Action to Benefit Independence & Thinking) program, extending clinic-based cognitive rehabilitation into the home.
- **Medicare GUIDE Program** — Longitudinal, value-based dementia care delivered under the CMS Innovation GUIDE Model at no cost to eligible Medicare beneficiaries and their families, spanning early cognitive impairment through end-stage dementia.
- **Virtual Interdisciplinary Care Team** — A remote clinical team of advanced practice nurses, licensed social workers, pharmacists and care navigators, supervised by neurologists and geriatric psychiatrists, providing 24/7 wraparound support for patients and care partners.
- **NG-001** — An early-stage prescription digital therapeutic (software) for Alzheimer's disease using AI/machine learning, adaptive cognitive tasks and reminiscence therapy to personalize treatment.

## Achievements

- Selected for the CMS Innovation Center's GUIDE Model for value-based dementia care
- Raised $12.3M total, including a $10M Series A led by Openspace Ventures and EDBI
- Established a multi-year collaboration with Mayo Clinic on the Neuroglee Connect platform
- Backed by pharmaceutical company Eisai and prominent healthtech founders/executives
- Relocated HQ to Boston in 2021 to tap the city's digital-health ecosystem

## Latest updates

- **2025-08** — Expanded strategic collaboration with Mayo Clinic to launch at-home dementia and cognitive care solutions, tied to enrollment in the CMS GUIDE Model.
- **2021-09** — Closed a $10M Series A led by Openspace Ventures and EDBI and relocated headquarters to Boston.
- **2021-09** — Announced Neuroglee Connect platform collaboration with Mayo Clinic to bring the HABIT program into home-based care.

## Links

- Website: https://neuroglee.com
- LinkedIn: https://www.linkedin.com/company/neuroglee-health/
- Twitter/X: https://twitter.com/neuroglee
- Instagram: https://www.instagram.com/neuroglee/
- Facebook: https://www.facebook.com/profile.php?id=61575147346784

---

Profile page: https://yespress.io/neuroglee-health
Published by YesPress — https://yespress.io
Last updated: 2026-07-18